featured
Long-Term Outcome and Prognostic Value of Ki67 After Perioperative Endocrine Therapy in Postmenopausal Women With Hormone-Sensitive Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Outcome and Prognostic Value of Ki67 After Perioperative Endocrine Therapy in Postmenopausal Women With Hormone-Sensitive Early Breast Cancer (POETIC): An Open-Label, Multicentre, Parallel-Group, Randomised, Phase 3 Trial
Lancet Oncol 2020 Nov 01;21(11)1443-1454, I Smith, J Robertson, L Kilburn, M Wilcox, A Evans, C Holcombe, K Horgan, C Kirwan, E Mallon, M Sibbering, A Skene, R Vidya, M Cheang, J Banerji, J Morden, K Sidhu, A Dodson, JM Bliss, M DowsettFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.